Health Organizations

Organizations around the world

World Health Organization

WHO releases COVID-19 roadmap; funding efforts, the roadmap announced (US$42.8 million) toward the development of vaccines, therapeutics and diagnostic test. WHO has received applications for review and approval of 40 diagnostic tests, 20 vaccines and an (unspecified) number of therapeutics. There are more than 200 clinical trials targeting COVID-19 progressing in China. Those include 35 studies evaluating antivirals and other agents, including remdesivir (GS-5734), the protease inhibitor combination drug Kaletra (lopinavir +ritonavir), Truvada (tenofovir),Tamiflu (oseltamivir), Xofluza (baloxavir marboxil), Arbidol (umifenovir), interferon drugs, the antimalarial drug chloroquine, and Lianhua-Qingwen, a traditional Chinese medicine for treating flu.


March 11, 2020 - Declared global pandemic by the World Health Organization on March 11, 2020


National Library of Medicine



Recommendations for U.S. Households with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19)


Coronavirus Resources

Covid 19 Alert


Products with Emerging Viral Pathogens AND Human Coronavirus claims for use against SARS-CoV-2


FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

Treatment research

Several organizations around the world are developing vaccinesor testing antiviralmedicine. Efforts include:

June 25 - 254 Treatments and 172 Vaccines

Explore detailed information on each development:

Doctors Without Borders

Red Cross Store:first-aid-supplies

Pharmaceutical Research and Manufacturers of America